Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

The role of radiotherapy in local control of nonextremity Ewing sarcomas.

Akagunduz OO, Kamer SA, Kececi B, Demirag B, Oniz H, Kantar M, Cetingul N, Sabah D, Anacak Y.

Tumori. 2016 Mar-Apr;102(2):162-7. doi: 10.5301/tj.5000478. Epub 2016 Feb 19.

PMID:
26917407
2.

Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.

Pan HY, Morani A, Wang WL, Hess KR, Paulino AC, Ludwig JA, Lin PP, Daw NC, Mahajan A.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):349-57. doi: 10.1016/j.ijrobp.2015.01.022. Epub 2015 Mar 12.

3.

Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors.

Choi Y, Lim DH, Lee SH, Lyu CJ, Im JH, Lee YH, Suh CO.

Cancer Res Treat. 2015 Oct;47(4):904-12. doi: 10.4143/crt.2014.158. Epub 2015 Feb 16.

4.

Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control.

Talleur AC, Navid F, Spunt SL, McCarville MB, Wu J, Mao S, Davidoff AM, Neel MD, Krasin MJ.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):119-26. doi: 10.1016/j.ijrobp.2016.04.001. Epub 2016 Apr 12.

5.

Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience.

Denbo JW, Shannon Orr W, Wu Y, Wu J, Billups CA, Navid F, Rao BN, Davidoff AM, Krasin MJ.

Ann Surg Oncol. 2012 Nov;19(12):3809-15. doi: 10.1245/s10434-012-2449-5. Epub 2012 Jul 3.

6.

Primary cutaneous and subcutaneous Ewing sarcoma.

Di Giannatale A, Frezza AM, Le Deley MC, Marec-Bérard P, Benson C, Blay JY, Bui B, Judson I, Oberlin O, Whelan J, Gaspar N.

Pediatr Blood Cancer. 2015 Sep;62(9):1555-61. doi: 10.1002/pbc.25535. Epub 2015 Apr 20.

PMID:
25894676
7.

Intraoperative Electron-Beam Radiation Therapy for Pediatric Ewing Sarcomas and Rhabdomyosarcomas: Long-Term Outcomes.

Sole CV, Calvo FA, Polo A, Cambeiro M, Gonzalez C, Desco M, Martinez-Monge R.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1069-1076. doi: 10.1016/j.ijrobp.2015.04.048. Epub 2015 May 2.

PMID:
26194682
8.

Prognostic factors for local and distant control in Ewing sarcoma family of tumors.

Rodríguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ.

Ann Oncol. 2008 Apr;19(4):814-20. Epub 2007 Nov 12.

PMID:
17998282
9.

Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.

Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, Claude L, Seddon B, Marec-Berard P, Whelan J, Paulussen M, Streitbuerger A, Oberlin O, Juergens H, Grimer R, Le Deley MC.

Eur J Cancer. 2016 Jul;61:128-36. doi: 10.1016/j.ejca.2016.03.075. Epub 2016 May 10.

PMID:
27176931
10.

Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.

Ataergin S, Ozet A, Solchaga L, Turan M, Beyzadeoglu M, Oysul K, Arpaci F, Komurcu S, Surenkok S, Ozturk M.

Med Oncol. 2009;26(3):276-86. doi: 10.1007/s12032-008-9115-6. Epub 2008 Nov 7.

PMID:
18989798
11.

Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?

Albergo JI, Gaston CLL, Parry MC, Laitinen MK, Jeys LM, Tillman RM, Abudu AT, Grimer RJ.

Bone Joint J. 2018 Feb;100-B(2):247-255. doi: 10.1302/0301-620X.100B2.BJJ-2017-0222.R1.

PMID:
29437069
12.
13.

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H.

J Clin Oncol. 2001 Mar 15;19(6):1818-29.

PMID:
11251014
14.

Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group.

Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL.

Ann Surg Oncol. 2016 Oct;23(11):3541-3547. doi: 10.1245/s10434-016-5269-1. Epub 2016 May 23.

15.

Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.

Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Gorlick RG, Laack NNI.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1286-1294. doi: 10.1016/j.ijrobp.2017.08.020. Epub 2017 Aug 24.

16.

Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

Tural D, Molinas Mandel N, Dervisoglu S, Oner Dincbas F, Koca S, Colpan Oksuz D, Kantarci F, Turna H, Selcukbiricik F, Hiz M.

Jpn J Clin Oncol. 2012 May;42(5):420-6. doi: 10.1093/jjco/hys027. Epub 2012 Mar 12.

PMID:
22416252
17.

Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.

Tao HT, Hu Y, Wang JL, Cheng Y, Zhang X, Wang H, Zhang SJ.

Asian Pac J Cancer Prev. 2013;14(5):2967-71.

18.

Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.

Oksüz DC, Tural D, Dincbas FÖ, Dervisoglu S, Turna H, Hiz M, Kantarci F, Ceylaner B, Koca S, Mandel NM.

Tumori. 2014 Jul-Aug;100(4):452-8. doi: 10.1700/1636.17910.

PMID:
25296596
19.

Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma.

Merchant TE, Kushner BH, Sheldon JM, LaQuaglia M, Healey JH.

Med Pediatr Oncol. 1999 Aug;33(2):65-70.

PMID:
10398178
20.

Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Sharma DN, Thulkar S, Vishnubhatla S, Pathania S, Bakhshi S.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9. doi: 10.1016/j.clon.2014.05.006. Epub 2014 Jun 8.

PMID:
24919857

Supplemental Content

Support Center